11 May 2016
BIND Therapeutics Announces Collaboration with Affilogic to Provide BIND with Access
to Targeting Ligands that are Key Modulators of Anti-tumor Immunity
BIND Therapeutics Announces Collaboration with Affilogic to Provide BIND with Access
to Targeting Ligands that are Key Modulators of Anti-tumor Immunity